Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Treasury Shares (2023 - 2025)

Camp4 Therapeutics' Treasury Shares history spans 3 years, with the latest figure at $4277.0 for Q1 2025.

  • For Q1 2025, Treasury Shares changed N/A year-over-year to $4277.0; the TTM value through Mar 2025 reached $4277.0, changed N/A, while the annual FY2024 figure was $15943.0, 78.53% down from the prior year.
  • Treasury Shares for Q1 2025 was $4277.0 at Camp4 Therapeutics, down from $15943.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $74243.0 in Q4 2023 and bottomed at $4277.0 in Q1 2025.
  • The 3-year median for Treasury Shares is $23275.0 (2024), against an average of $31267.5.
  • The largest YoY upside for Treasury Shares was 78.53% in 2024 against a maximum downside of 78.53% in 2024.
  • A 3-year view of Treasury Shares shows it stood at $74243.0 in 2023, then tumbled by 78.53% to $15943.0 in 2024, then plummeted by 73.17% to $4277.0 in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Treasury Shares are $4277.0 (Q1 2025), $15943.0 (Q4 2024), and $30607.0 (Q3 2024).